Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 0 |
| Since 2007 (last 20 years) | 2 |
Descriptor
Author
| Asgari, Karim | 1 |
| Buis, Tom | 1 |
| Chitsaz, Ahmad | 1 |
| Emsaki, Golit | 1 |
| Fresco, David M. | 1 |
| Kennedy, Sydney | 1 |
| Molavi, Hossein | 1 |
| Segal, Zindel V. | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Beck Depression Inventory | 2 |
| Beck Anxiety Inventory | 1 |
What Works Clearinghouse Rating
Peer reviewed
Download full textEmsaki, Golit; Asgari, Karim; Molavi, Hossein; Chitsaz, Ahmad – Psicologica: International Journal of Methodology and Experimental Psychology, 2013
In the present study, the effectiveness of 3 drug regimen on cognitive performance of PD patients was compared. 12 patients who had been using pramipexole, levodopa and amantadine for at least 1 month entered the study and compared with those 12 who had been using trihexiphenidyle, levodopa and amantadine. There was also a control group…
Descriptors: Drug Therapy, Diseases, Neurological Impairments, Patients
Direct linkFresco, David M.; Segal, Zindel V.; Buis, Tom; Kennedy, Sydney – Journal of Consulting and Clinical Psychology, 2007
Z. V. Segal et al. (2006) demonstrated that depressed patients treated to remission through either antidepressant medication (ADM) or cognitive-behavioral therapy (CBT), but who evidenced mood-linked increases in dysfunctional thinking, showed elevated rates of relapse over 18 months. The current study sought to evaluate whether treatment response…
Descriptors: Patients, Depression (Psychology), Correlation, Drug Therapy
